What they are
Triglycerides are fat in transit
A triglyceride is the form in which the body stores and transports most of its fat. The molecule is made of one glycerol backbone with three fatty acids attached, hence the name. When you eat fat, most of it is packaged into triglycerides inside intestinal cells and shipped through the bloodstream as chylomicrons to be either burned for energy or stored. When you eat more carbohydrate than the body needs in the moment, the liver converts the excess into triglycerides through a process called de novo lipogenesis and exports them into circulation packaged in very-low-density lipoprotein, or VLDL.[1]
This is the first thing that surprises most people about triglycerides. The number on a lipid panel reflects fat in transit through the blood, but a large fraction of that fat was assembled by the liver out of carbohydrate, not eaten as fat in the first place. Fructose is the clearest example, because it is metabolized almost entirely in the liver and is a particularly potent driver of de novo lipogenesis. In a controlled ten-week study, overweight adults who drank fructose-sweetened beverages supplying a quarter of their energy increased de novo lipogenesis, developed dyslipidemia, and lost insulin sensitivity, while those drinking glucose-sweetened beverages did not, even though both groups gained similar weight.[4] This is why a diet high in refined carbohydrate and added sugar reliably elevates fasting triglycerides even in the absence of meaningful fat consumption, and why the low-fat era, which replaced fat with refined starch and sugar, so often produced rising triglycerides rather than falling ones.
The numbers, in plain English
What the normal range actually says
A standard fasting lipid panel categorizes triglycerides into roughly these bands (units are mg/dL, as used in the United States):
- Normal: below 150 mg/dL
- Borderline high: 150 to 199 mg/dL
- High: 200 to 499 mg/dL
- Very high: 500 mg/dL and above
Outside the United States, the same panel is usually reported in mmol/L. The conversion factor is 0.0113. So 150 mg/dL is approximately 1.7 mmol/L. The bands are otherwise identical.
There is an important nuance the "normal" label hides. A triglyceride number under 150 mg/dL is the official cutoff for "normal," but the metabolic literature has converged on a much more demanding optimal range. A fasting triglyceride below 100 mg/dL (about 1.1 mmol/L) is the genuine optimum.[1] Numbers between 100 and 150 are technically normal but increasingly recognized as a sign of early insulin resistance: in overweight adults, a fasting triglyceride at or above roughly 130 mg/dL is one of the single most useful lipid-panel markers for identifying insulin resistance.[5] Numbers between 75 and 100 are characteristic of metabolically healthy populations. Numbers below 75 are common in plant-based eaters, in regular fasters, and in trained endurance athletes.
This matters because a person told their triglycerides are "normal" at 140 mg/dL may be reassured at the moment they should be informed. The lab range is a population threshold for clinical concern, not a target for health.
Why this number is so informative
Triglycerides as a metabolic mirror
Of all the lines on a standard lipid panel, fasting triglycerides are the most responsive to short-term metabolic changes and the most informative about insulin sensitivity. Total cholesterol moves slowly and is heavily influenced by genetics. LDL cholesterol is informative but takes months to shift meaningfully. HDL is slow to respond. Triglycerides, by contrast, can change measurably within weeks of an eating-pattern shift, and they track how well the body is handling carbohydrate, fat storage, and overall metabolic load.
The ratio of triglycerides to HDL cholesterol is particularly useful as a proxy for insulin resistance. In overweight adults, a triglyceride-to-HDL-cholesterol ratio at or above 3.0 (using mg/dL) identifies insulin resistance about as well as the full set of metabolic-syndrome criteria, while a low ratio is a strong sign of preserved metabolic flexibility.[5] The ratio is calculable from any standard lipid panel and is one of the most overlooked metabolic signals in routine bloodwork.
This is also why a triglyceride number is rarely abnormal on its own. The Health Protocol reads it inside a cluster: the NHLBI and the American Heart Association both note that abdominal obesity, elevated triglycerides, lower HDL cholesterol, raised blood pressure, and higher fasting glucose tend to travel together as metabolic syndrome, a pattern now estimated to affect roughly a quarter of adults worldwide.[2] The point, in the book's framing, is not to moralize body size but to recognize that central fat accumulation often signals a terrain in which insulin demand, inflammatory signaling, and cardiometabolic risk are moving in the wrong direction together. A rising triglyceride is one of the earliest readable lines in that shared drift.
What raises them, in order of impact
The inputs that move the number up
Triglycerides rise reliably in response to:
- Refined carbohydrate and added sugar, particularly fructose, which is processed almost entirely by the liver and drives de novo lipogenesis directly.[4]
- Alcohol, which the liver prioritizes for processing and which suppresses fat oxidation. Even modest regular alcohol use produces measurable triglyceride elevation in most people.
- Recent eating. A triglyceride number drawn within hours of a fat-containing meal can be temporarily elevated by 50 to 100 percent, which is why standard lipid panels are drawn fasting (10 to 12 hours). Nonfasting values are not merely noise, however: in large population cohorts, elevated nonfasting triglycerides independently predict heart attack, ischemic heart disease, and death, which is part of why nonfasting panels are increasingly accepted in practice.[6]
- Insulin resistance and visceral adiposity, which together raise the rate at which the liver releases triglycerides into circulation.
- Sedentary behavior, which reduces skeletal muscle's uptake and oxidation of circulating fat.
- Untreated hypothyroidism, certain medications (beta blockers, thiazide diuretics, oral estrogens, some antiretrovirals), and pregnancy.
What lowers them, in order of impact
The inputs that move the number down
Triglycerides fall reliably in response to:
- Reducing refined carbohydrate and added sugar. This is the single highest-leverage dietary change for elevated triglycerides. Many people see 30 to 50 percent drops within weeks of this change alone.
- Plant-based eating patterns, which combine low refined-carbohydrate density with high fiber that slows fat absorption and improves insulin sensitivity. Randomized trials find vegetarian and vegan patterns lower total and LDL cholesterol and apolipoprotein B, and improve markers of insulin sensitivity.[T2][10]
- Time-restricted eating, which extends the daily fasting window during which the liver clears circulating fat. A twelve-week trial of ten-hour time-restricted eating in people with metabolic syndrome reduced weight, blood pressure, and atherogenic lipids.[3]
- Daily moderate movement, especially after meals, which improves muscle uptake of triglycerides for oxidation.
- Reducing or eliminating alcohol. Often produces a 20 to 40 percent triglyceride drop in heavy drinkers within weeks of cessation.
- Omega-3 intake, particularly EPA and DHA from fatty fish or algal oil, which has a direct lowering effect at higher doses. A 2019 American Heart Association science advisory concluded that 4 grams per day of prescription omega-3 lowers triglycerides by roughly 20 to 30 percent, and by more than 30 percent in severe cases, without raising LDL cholesterol.[9]
- Treating underlying insulin resistance or thyroid dysfunction when present.
When triglycerides are very high
The clinical concern threshold
Between the optimal range and the very high range sits the question most people actually face: does a moderately elevated triglyceride matter for the heart? The American Heart Association's scientific statement on triglycerides and cardiovascular disease treats fasting triglycerides as an independent marker of cardiovascular risk and sets the optimal level below 100 mg/dL.[1] Pooled across twenty-nine Western prospective studies covering more than ten thousand coronary events, higher triglycerides were independently associated with coronary heart disease after adjustment for other risk factors.[7] Genetic and Mendelian-randomization studies have since moved the case from association toward causation: the triglyceride-rich remnant lipoproteins the liver exports appear to contribute directly to atherosclerotic cardiovascular disease rather than merely mark it.[8] This is the larger reason a triglyceride is worth reading carefully well before it reaches any clinical threshold.
Triglycerides above 500 mg/dL are a separate clinical category. At this level the risk of acute pancreatitis rises significantly, and aggressive intervention is warranted. People in this range should be working with a clinician. The first-line interventions remain dietary (sharp reduction of refined carbohydrate, alcohol elimination, weight loss) but may be supplemented with pharmacological options, including high-dose prescription omega-3, fibrates, and niacin in selected cases, depending on the clinical picture.[9]
For the much more common situation of triglycerides between 150 and 300 mg/dL, the framework is the same one developed throughout The Health Protocol. The number is a signal, not a disease. It is responding to the inputs the body is receiving. Change the inputs and the number changes, and the cardiovascular risk it reflects tends to change with it, especially under the kind of whole-food, plant-forward pattern with the strongest convergent evidence for coronary protection.[T1]
Where this lives in The Health Protocol
Mapped to the book
Triglycerides are part of the larger biomarker conversation in Chapters V and VI of The Health Protocol, which cover metabolic health and the cardiovascular consequences of metabolic dysfunction. The dietary patterns that move triglycerides are developed throughout Module 2 (Nourishment by Design) and the metabolic logic is the spine of Module 3 of the seminar (Metabolic Coherence).
The point is not to moralize body size. It is to recognize that central fat accumulation often signals a terrain in which insulin demand, inflammatory signaling, and cardiometabolic risk are moving in the wrong direction together.
The Health Protocol · Chapter V · p. 96
Frequently asked questions
What are triglycerides?
A triglyceride is the form in which the body stores and transports most of its fat: one glycerol backbone with three fatty acids attached. The number on a standard lipid panel reflects fat in transit through the blood, much of which the liver assembles out of excess carbohydrate rather than dietary fat. A fasting level below 100 mg/dL is the genuine optimum; the official “normal” cutoff of 150 mg/dL is a threshold for clinical concern, not a target for health.
What does a high triglyceride number tell you?
A fasting triglyceride is one of the most responsive and informative single lines on a lipid panel: it tracks insulin sensitivity, and the triglyceride-to-HDL ratio is a useful proxy for insulin resistance. Elevated triglycerides also travel with the rest of the metabolic-syndrome cluster, and even moderately raised levels are independently associated with coronary heart disease, with genetic evidence pointing toward a causal role for triglyceride-rich remnant lipoproteins.
Are high triglycerides a disease to treat?
As a signal, not a disease. The seminar treats the number as a readout of the inputs the body is receiving (refined carbohydrate and added sugar, alcohol, sedentary time, sleep, and visceral fat) and works on those inputs. Reducing refined carbohydrate and sugar is the single highest-leverage change; plant-forward eating, time-restricted eating, daily movement, and where appropriate omega-3 all help. Levels above 500 mg/dL are a separate clinical category that warrants working with a clinician.
What lowers high triglycerides most effectively?
For most people, the inputs the number is reading: less refined carbohydrate and added sugar, less alcohol, more movement, and weight reduction where relevant, often supported by omega-3-rich foods. Triglycerides are among the most responsive lines on a lipid panel, so these changes can move the number within weeks. A very high reading, or one that does not respond, warrants clinical evaluation rather than self-management alone.
Primary references from The Health Protocol bibliography
These papers are cited in the canonical bibliography of The Health Protocol. Full bibliography at thejourneybeginswithin.com/health/references/.
- [T1]Satija A, Bhupathiraju SN, Spiegelman D, et al. Healthful and unhealthful plant-based diets and the risk of coronary heart disease in U.S. adults. Journal of the American College of Cardiology. 2017;70(4):411 to 422. The study distinguished healthful from unhealthful plant-based patterns and found sharply different coronary risk associations. TJBW [4.11]
- [T2]Koch M, Hjorth MF, Sjodin A, et al. Vegetarian or vegan diets and blood lipids: a meta-analysis of randomized trials. European Heart Journal. 2023;44(28):2609 to 2622. Vegetarian and vegan dietary patterns were associated with lower total cholesterol, low density lipoprotein cholesterol, and apolipoprotein B. TJBW [4.12]
Additional references cited in this article
All claims above are sourced to peer-reviewed literature. The numbered list below corresponds to the inline citations. The full bibliography for The Health Protocol is available at thejourneybeginswithin.com/health/references/.
- [1]Michael Miller et al.. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292 to 2333. AHA scientific statement on triglycerides and cardiovascular risk: optimal fasting triglycerides below 100 mg/dL, with the triglyceride/HDL ratio as a useful proxy for insulin resistance. doi.org/10.1161/CIR.0b013e3182160726
- [2]Mohammad G. Saklayen. The global epidemic of the metabolic syndrome. Current Hypertension Reports. 2018;20(2):12. Review of the global prevalence of metabolic syndrome (estimated one-quarter of adults worldwide) and its components (visceral adiposity, dyslipidemia, hypertension, insulin resistance). doi.org/10.1007/s11906-018-0812-z
- [3]Michael J. Wilkinson et al.. Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metabolism. 2020;31(1):92 to 104.e5. Twelve-week trial of 10-hour time-restricted eating in patients with metabolic syndrome producing measurable reductions in weight, blood pressure, and atherogenic lipid markers. doi.org/10.1016/j.cmet.2019.11.004
- [4]Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. Journal of Clinical Investigation. 2009;119(5):1322 to 1334. Over ten weeks, fructose-sweetened but not glucose-sweetened beverages at 25 percent of energy raised de novo lipogenesis and visceral fat, promoted dyslipidemia, and reduced insulin sensitivity, despite similar weight gain. doi.org/10.1172/JCI37385
- [5]McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine. 2003;139(10):802 to 809. A fasting triglyceride near 130 mg/dL and a triglyceride/HDL-cholesterol ratio near 3.0 identified insulin-resistant overweight adults with accuracy comparable to the full metabolic-syndrome criteria. doi.org/10.7326/0003-4819-139-10-200311180-00007
- [6]Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299 to 308. In a Copenhagen cohort of nearly 14,000 adults, elevated nonfasting triglycerides independently predicted myocardial infarction, ischemic heart disease, and death. doi.org/10.1001/jama.298.3.299
- [7]Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007;115(4):450 to 458. Higher triglycerides were independently associated with coronary heart disease after adjustment for established risk factors, with adjusted odds ratios near 1.6 to 1.8. doi.org/10.1161/CIRCULATIONAHA.106.637793
- [8]Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. The Lancet. 2014;384(9943):626 to 635. A review of genetic and Mendelian-randomization evidence indicating that triglyceride-rich remnant lipoproteins are causally associated with cardiovascular disease, not merely a marker of it. doi.org/10.1016/S0140-6736(14)61177-6
- [9]Skulas-Ray AC, Wilson PWF, Harris WS, et al. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation. 2019;140(12):e673 to e691. At 4 grams per day, prescription omega-3 lowers triglycerides by about 20 to 30 percent, and by more than 30 percent in severe hypertriglyceridemia, without raising LDL cholesterol. doi.org/10.1161/CIR.0000000000000709
- [10]Termannsen AD, Sondergaard CS, Faerch K, et al. Effects of plant-based diets on markers of insulin sensitivity: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2024;16(13):2110. Plant-based dietary patterns improved fasting insulin and HOMA-IR in adults with overweight or obesity. doi.org/10.3390/nu16132110